GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Local medical device companies last month posted fourth quarter results that exceeded analysts’ expectations.Irvine’s Masimo ...

Glaukos Corporation GKOS reported record fourth-quarter 2024 revenues of $105.5 million, reflecting a 28% year-over-year increase. This growth was driven by strong demand for its innovative glaucoma ...

Glaukos Corporation GKOS reported fourth-quarter 2024 adjusted loss of 40 cents per share, narrower than the Zacks Consensus ...

As we pass the 1-year anniversary of our controlled launch of iDose TR, I could not be more pleased with our team's execution of our plans for this first-of-its-kind intracameral procedural ...

In other recent news, Glaukos Corporation has reported promising developments regarding its iDose TR product, with clinical trials demonstrating sustained efficacy in reducing intraocular pressure ...

In this Healio Video Perspective, Zarmeena Vendal, MD, discusses her positive experience with the Voyager direct selective laser trabeculoplasty device and its contribution to interventional ...